Product Information
67381-1-PBS targets TSG101 in WB, IHC, IF/ICC, IF-P, FC (Intra), ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Host / Isotype | Mouse / IgG1 |
| Class | Monoclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag28569 Product name: Recombinant human TSG101 protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 214-390 aa of BC002487 Sequence: GPSRDGTISEDTIRASLISAVSDKLRWRMKEEMDRAQAELNALKRTEEDLKKGHQKLEEMVTRLDQEVAEVDKNIELLKKKDEELSSALEKMENQSENNDIDEVIIPTAPLYKQILNLYAEENAIEDTILYLGEALRRGVIDLDVFLKHVRLLSRKQFQLRALMQKARKTAGLSDLY Predict reactive species |
| Full Name | tumor susceptibility gene 101 |
| Calculated Molecular Weight | 44 kDa |
| Observed Molecular Weight | 43-46 kDa |
| GenBank Accession Number | BC002487 |
| Gene Symbol | TSG101 |
| Gene ID (NCBI) | 7251 |
| RRID | AB_2882628 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Protein G purification |
| UNIPROT ID | Q99816 |
| Storage Buffer | PBS only, pH 7.3. |
| Storage Conditions | Store at -80°C. |
Background Information
TSG101(Tumor susceptibility gene 101 protein) is essential for endosomal sorting, membrane receptor degradation and the final stages of cytokinesis. It plays a crucial role for cell proliferation and cell survival. TSG101 has been identified as a candidate tumor suppressor gene and belongs to the ubiquitin-conjugating enzyme family. TSG101 is a marker for exosome. This protein has 2 isoforms produced by alternative splicing with the molecular mass of 44 and 32 kDa.
Publications
What published studies show
TSG101 Monoclonal antibody (Cat. 67381-1-PBS, PBS Only) has 1 citation in total. The citation appears in the journal Oncology Letters (2026), authored by Yunfeng Weng. The associated research field is oncology/cancer biology, specifically the study of exosomal miR-145-5p in papillary thyroid cancer, involving the targeting of TPM3 and inactivation of the PI3K-Akt signaling pathway.
| Species | Application | Title |
|---|---|---|
Oncol Lett Exosomal miR-145-5p inhibits papillary thyroid cancer by targeting TPM3 and inactivating the PI3K-Akt pathway. |



















